Skip to main content
. Author manuscript; available in PMC: 2015 Apr 28.
Published in final edited form as: J Thorac Oncol. 2014 Apr;9(4):554–558. doi: 10.1097/JTO.0000000000000052

Figure 3.

Figure 3

The results from next generation sequencing on Tumor 2 (T2), Tumor 3 (T3), Tumor 4 (T4) and normal blood. The EGFR T790M point mutation was identified in all samples. In addition to EGFR T790M, T2 had evidence of an ARID1A K1938N mutation, and T3 and T4 had evidence of an EGFR L858R point mutation.